Iovance Biotherapeutics, Inc. - Common Stock (IOVA)

There's an incredible growth story hiding in plain sight for investors who can look to the future.

The time to buy quality prospects is when the rest of the market is ignoring their value.

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

The market's underestimating how well each of these companies should be able to capitalize on their opportunities.

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.

A handful of bullish factors are converging at the right time in the right way for all three of these companies.

Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) are trading lower Friday. The company announced the inducement stock option grants under Nasdaq Listing Rule 5635(c)(4).

These windows of opportunity aren't likely to remain open for much longer.

Just be ready to ride out some inevitable turbulence along the way.